Japan spends consistently over 3% of its GDP on R&D, of which some 70% come from industry. Concerning biotech-related R&D, more than half is directed towards pharmaceutical and medical goals, but agricultural, industrial and environmental biotech are recently getting more attention in view of a future “bioeconomy” based on “smart cells” and a better integration of biological and digital innovations. Japanese industry, supported by long-term government programs, is eager to identify such innovations world-wide, and mechanisms which are in place to establish international partnerships will be discussed.
The webinar is targeted to start-ups with innovative biotech-related products or services that look for funding from Japanese medical, agricultural, chemical or environmental industries.
In 40 minutes from your desk, discover the:
Registration deadline: 20 Septembre 2021
Speaker: : Dr Rolf Schmid, CEO. Bio4Business, Stuttgart, Germany. Mr Schmid studied biochemistry and microbiology at the Universities of Munich and Freiburg in Germany. After obtaining his doctor degree, he became a post-doctoral researcher at the CNRS in Gif-sur-Yvette and at the University of Texas in Austin. He joined Henkel KGaA in Dusseldorf as a research scientist and served 15 years as head of biotechnology R&D of this company, before leaving for a directorate at a Helmholtz-Centre in Braunschweig coupled to a chair at Braunschweig University. 7 years later, he moved to Stuttgart University as Director of the Institute of Technical Biochemistry. In 2009, he founded Bio4Business, a consulting company in Stuttgart which profits from his 40 years experience on joint research projects with Japanese companies and academia, including a 3 months sabbatical at the University of Tokyo.
Moderator: Pauline Laloux, Business Support Coordinator, EU-Japan Centre
Organiser: EU-Japan Centre for Industrial Cooperation - Brussels Office
The EU-Japan Centre currently produces 5 newsletters :